FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely neurology, and can be used in treating cataplesis. Method according to the invention involves administering to a subject a therapeutically effective amount of a compound of formula
(Ib).
EFFECT: using the invention enables improving the patients state by reducing the number of weekly cataplexies.
12 cl, 7 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS (VERSIONS) | 2006 |
|
RU2417077C2 |
| METHODS OF TREATMENT OF BIPOLAR DISORDER | 2011 |
|
RU2653408C2 |
| 1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATING COCHLEAR TINNITUS | 2008 |
|
RU2438658C2 |
| INTERVAL THERAPY FOR TREATING TINNITUS | 2008 |
|
RU2446794C2 |
| METHOD OF TREATING FIBROMYALGIA SYNDROME | 2010 |
|
RU2557533C2 |
| 1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATING AND PREVENTING HEARING LOSS | 2008 |
|
RU2452476C2 |
| NERAMEXANE TITRATION KIT AND USING IT IN TREATING INTERNAL EAR DISORDERS | 2008 |
|
RU2459618C2 |
| THERAPY FOR TREATING DISEASE | 2006 |
|
RU2435610C2 |
| COMBINATION OF PI3 KINASE INHIBITOR WITH PACLITAXEL FOR USE IN TREATMENT OR PREVENTION OF HEAD AND NECK CANCER | 2014 |
|
RU2672555C2 |
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
